As I mentioned before, Arrowhead is a very interesting group. We'll keep an eye on them.
Arrowhead Research Subsidiary, Insert Therapeutics, Treats First Patient with Nano-Engineered Anti-Cancer Therapeutic: "PASADENA, Calif.—(BUSINESS WIRE)—July 19, 2006— Arrowhead Research Corporation (Nasdaq:ARWR), announced today that its majority-own"
(Via NanoTechCafe.com CorpNews.)
Insert Therapeutics have filed a number of patents and with a curious pattern of filing in US Mexico and China?? Below the Mexican patents Click here to see Espace@net's records
MXPA05003591 Abstract of MXPA05003591 The application discloses cyclodextrin-modified materials for carrying drugs and other active agents, such as nucleic acids. Compositions are also disclosed of cyclodextrin-modified materials that release such active agents under controlled conditions. The invention also discloses compositions of cyclodextrin-modified polymer carriers that are coupled to biorecognition molecules for assisting the delivery of drugs to their site of action. Abstract of
MXPA05002444 The present invention relates to novel compositions of therapeutic cyclodextrin containing polymeric compounds designed as a carrier for small molecule therapeutics delivery and pharmaceutical compositions thereof. These cyclodextrin-containing polymers improve drug stability and solubility, and reduce toxicity of the small molecule therapeutic when used in vivo. Furthermore, by selecting from a variety of linker groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein. The invention further relates to methods for conducting pharmaceutical business comprising manufacturing, licensing, or distribution kits containing or relating to the polymeric compounds described herein.